Inotiv, Inc. Amends Its Credit Agreement and Secures Additional Liquidity
September 16, 2024 08:00 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical...
Inotiv to Participate in the 8th Annual Lake Street Best Ideas Growth Conference
August 28, 2024 16:05 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in nonclinical and analytical drug discovery and...
Inotiv Reports Third Quarter Financial Results for Fiscal 2024 and Provides Business Update
August 08, 2024 16:05 ET
|
Inotiv, Inc.
— Third quarter fiscal 2024 revenue down 32.8% to $105.8 million — Year-to-date fiscal 2024 revenue down 16.5% to $360.3 million — Conclusion of certain government investigations — Site optimization...
Inotiv, Inc. to Report Fiscal 2024 Third Quarter Financial Results and Host Conference Call on Thursday, August 8, 2024
July 25, 2024 08:00 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., July 25, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical...
Inotiv, Inc. Provides Business Updates
June 10, 2024 07:30 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., June 10, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical...
Inotiv Reaches Agreement to Resolve Previously-Announced Investigation into Shuttered Cumberland Facility
June 03, 2024 13:24 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., June 03, 2024 (GLOBE NEWSWIRE) -- Inotiv Inc. – Inotiv Inc. (“Inotiv” or the “Company”) (Nasdaq: NOTV), a leading contract research organization dedicated to providing...
Inotiv, Inc. to Participate in Upcoming Craig Hallum and Jefferies Investor Conferences
May 23, 2024 16:15 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., May 23, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery...
Inotiv Reports Second Quarter Financial Results for Fiscal 2024 and Provides Business Update
May 15, 2024 16:05 ET
|
Inotiv, Inc.
— Second quarter fiscal 2024 revenue down 21.5% to $119.0 million— Year-to-date fiscal 2024 revenue down 7.2% to $254.5 million— Agreement in principle reached with the U.S. Department of Justice on...
Inotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Wednesday, May 15, 2024
May 14, 2024 07:00 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., May 14, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical...
Inotiv, Inc. Reschedules its Fiscal 2024 Second Quarter Results
May 09, 2024 18:56 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., May 09, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery...